Trump administration loophole snags US research grants from Lyme to lung disease
The Trump administration has for weeks been blocking the U.S.
The Trump administration has for weeks been blocking the U.S.
President Donald Trump's executive orders have begun to disrupt patient care in the United States, as some providers cannot access
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema amid a
The attorney general for one of the most populous U.S. states this week urged federal drug regulators to address safety risks associated with the widely
For many U.S. parents seeking help for a child with obesity, the most widely-endorsed treatment is out of reach - and it's not the popular weight-loss
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's weight-loss drug Wegovy last year, a powerful new tool to
Your subscription includes
Unlimited Access to All Content from
The Los Angeles Post
Your subscription has been successfully upgraded!